Target intelligence / Profile preview

Glutathione S-transferase Mu 5 (GSTM5)

Target
GSTM5
Molecular classification
Enzyme, Glutathione S-transferase, Phase II metabolic enzyme, Cytosolic protein
01

Overview

Glutathione S-transferase Mu 5 (GSTM5) is a cytosolic enzyme of the glutathione S-transferase (GST) mu class that catalyzes the conjugation of reduced glutathione to a wide range of electrophilic and hydrophobic substrates, including drugs, carcinogens, and products of oxidative stress[1][2][3]. GSTM5 is involved in cellular detoxification processes and protection from oxidative damage. The mu class GSTs are encoded by highly polymorphic genes, leading to variability in detoxification capacity, which may affect disease susceptibility and drug response in humans[3]. GSTM5 is located on chromosome 1p13.3 and is structurally related to other cytosolic GSTs, sharing the typical GST domain organization. While the biological roles of GSTM5 specifically have not been as extensively documented as those of other GST family members (such as GSTP1 or GSTM1), it is considered part of the cellular defense system against toxic insults and may be relevant to clinical outcomes involving drug metabolism and susceptibility to certain diseases[1][2][3].

Other names
GST class-mu 5GSTM5-5S-(hydroxyalkyl)glutathione lyase M5epididymis secretory sperm binding proteinglutathione S-alkyltransferase M5glutathione S-aralkyltransferase M5glutathione S-aryltransferase M5GTM52.5.1.18
02

Mechanism of action

Drugs interacting with GSTM5 are typically detoxified through enzymatic conjugation with glutathione (GSH), increasing water solubility and promoting elimination.

03

Biological functions

DetoxificationGlutathione conjugationProtection against oxidative stressCell signaling modulation
04

Disease associations

CancerBorderline glaucomaBarrett's adenocarcinomaDrug metabolism-related conditionsOther
05

Safety considerations

Polymorphic variations may influence detoxification efficiency, potentially impacting efficacy and toxicity of drugs and susceptibility to toxins
06

Interacting drugs

Not specifically documented for GSTM5; glutathione S-transferases (mu class, including GSTM5) can interact with chemotherapeutic agents, environmental toxins, and drugs subject to glutathione conjugation
07

Biomarkers

Genetic polymorphisms in GSTM5 and related mu class enzymes may be linked to individual susceptibility to carcinogens and drug toxicity; not specifically used as a clinical biomarker

Beyond the preview

Go deeper on Glutathione S-transferase Mu 5 (GSTM5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutathione S-transferase Mu 5 (GSTM5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call